Analyst
Systematics
Equibles does not estimate personal net worth.
Manchanda is recorded as Analyst at Systematics. Manchanda has spoken on 1 earnings call across 1 company, most recently for Sun Pharmaceutical Industries Limited on January 31, 2026. The companies whose calls Manchanda spoke on are classified in the Healthcare sector.
“A question on your pending ANDS and NDAs. So, you have 116 ANDA spending and about 14 NDA spending approvals. Would you be able to share how many of these are from sites that are impacted by OAI?”
Systematics
Analyst
Transcript header (unverified)
Sun Pharmaceutical Industries Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Sun Pharma Q3 FY26 Earnings Call Transcript
Sun Pharmaceutical Industries Limited
